Caesars Entertainment Celebrates the Launch of Remote Reels ™, Delivering an Unmatched Casino Floor Experience to Caesars Palace Online Casino Players
BUSINESS WIRE)--Caesars Entertainment, Inc. (NASDAQ: CZR) ('Caesars') today celebrated the launch of Remote Reels ™ at Tropicana Atlantic City, an innovative online casino enhancement that connects live slot gameplay from the casino floor directly to Caesars Palace Online Casino on mobile and desktop. This launch marks a major milestone in Caesars' continued efforts to bring a land-based casino experience to its online casino platforms by bringing top titles that are typically found on-site at Caesars Rewards destinations to players in this remote-to-cabinet format for the first time ever. Players can choose from a range of popular physical slot machines located inside the Remote Reels ™ studio at Tropicana Atlantic City and play them directly on their mobile devices.
Situated directly on the casino floor at Tropicana Atlantic City, the 937-square-foot Remote Reels™ studio, created in partnership with Awager, offers a thrilling new way to experience live slot action. Enclosed in glass walls, the studio features 25 slot machines that allow guests 21 and older to spin the reels via the Caesars Palace Online Casino app and play them remotely in real time. The studio is filled with popular titles from premier operators Light & Wonder and Aristocrat that are also available to customers at Caesars Rewards destinations across North America.
"We're proud to be the first online casino operator to have premier titles such as Huff N' Even More Puff, Mo' Mummy Valley of Riches, Mo' Mummy Mighty Pyramid and Buffalo Triple Boost in a remote-to-cabinet play format,' said Matthew Sunderland, Senior Vice President and Chief iGaming Officer at Caesars Digital. 'The debut of our state-of-the-art Remote Reels™ studio inside Tropicana Atlantic City is the latest example of the innovation we aim to deliver to our online casino players and represents the perfect blend of the familiar feeling of slot play on a casino floor at one of our Caesars Rewards destinations with a fully mobile experience.'
'The stunning new Remote Reels™ studio adds another exciting component to the Tropicana Atlantic City experience for our guests and players,' said Joseph Giunta, Senior Vice President and General Manager of Tropicana Atlantic City. 'We're proud to showcase this immersive space in the heart of our casino and give our online players the thrill of Atlantic City from the comfort of their own homes.'
To commemorate the exciting launch of Remote Reels ™, Caesars hosted popular online casino influencer, Slot Hopper at Tropicana Atlantic City to place the ceremonial first spin via a mobile device and provided a special look at the new technology for local media.
'We are incredibly proud to partner with Caesars Entertainment and Caesars Digital for the debut of Remote Reels™,' said Roy Greenbaum, Co-Founder & CEO of Awager. 'Bringing land-based play online is at the heart of our mission to deliver a truly authentic, immersive casino experience straight to players' devices. Streaming live from the iconic Tropicana Atlantic City underscores the unique entertainment value we offer our partners. The industry has been waiting for an innovation like this, and we're proud to launch it with a prominent brand like Caesars.'
The launch of Remote Reels ™ marks the latest innovation for Caesars' online casino platforms, which features Caesars Palace Online Casino, Caesars Sportsbook & Casino, Horseshoe Online Casino, Tropicana Online Casino, and WSOP Online. Last month, The Company celebrated its first online casino title fully developed by its newly established in-house games studio, with the launch of Caesars Palace Signature Multihand Blackjack Surrender. Earlier this year, The Company also debuted a branded live-dealer studio inside Tropicana Atlantic City, marking the first of such inside a Caesars Rewards destination and its second branded studio in operation.
Those 21 and older can download the Caesars Palace Online Casino app on iOS or Android, or by visiting the platform on desktop. Caesars Palace Online Casino, Horseshoe Online Casino, and Caesars Sportsbook & Casino are available for players 21 and older in New Jersey, Pennsylvania, Michigan, Ontario, and West Virginia. All online casino platforms are conveniently linked with Caesars Rewards, the industry-leading loyalty program. U.S. players can earn Caesars Rewards Credits, redeemable for unforgettable experiences at over 50 world-class Caesars destinations across North America
Caesars Entertainment is an industry leader in Responsible Gaming, known for pioneering Responsible Gaming awareness and education. In 1989, Caesars became the first commercial casino company to address problem gambling by launching the industry's first Responsible Gaming program, Project 21. Today, the Company's commitment to ensuring all players are aware of Responsible Gaming resources remains steadfast and spans all of Caesars' digital platforms and world-class destinations in which it operates. Caesars Entertainment proudly enforces an enhanced 21+ gaming policy that prevents individuals under the age of 21 from using Caesars Rewards and restricts access to its gaming products for individuals under the age of 21.
In March 2024, Caesars Sportsbook received the prestigious RG Check accreditation from the Responsible Gambling Council in Ontario, Canada, which recognizes companies that achieve the highest standards for their Responsible Gaming practices. Just a few months later, the Company was awarded the National Council on Problem Gambling's award for Corporate Social Responsibility. For more information about Caesars Entertainment's Responsible Gaming program, please visit https://www.caesars.com/corporate.
About Caesars Entertainment, Inc.
Caesars Entertainment, Inc. (NASDAQ: CZR) is the largest casino entertainment company in the U.S. and one of the world's most diversified casino entertainment providers. Since its beginning in Reno, NV, in 1937, Caesars Entertainment, Inc. has grown through the development of new resorts, expansions and acquisitions. Caesars Entertainment, Inc.'s resorts operate primarily under the Caesars®, Harrah's®, Horseshoe® and Eldorado® brand names. Caesars Entertainment, Inc. offers diversified gaming, entertainment and hospitality amenities, one-of-a-kind destinations, and a full suite of mobile and online gaming and sports betting experiences. All tied to its industry-leading Caesars Rewards® loyalty program, the company focuses on building value with its guests through a unique combination of impeccable service, operational excellence and technology leadership. Caesars is committed to its Team Members, suppliers, communities and the environment through its PEOPLE PLANET PLAY framework. Know When To Stop Before You Start.® Gambling Problem? Call 1-800-522-4700. For more information, please visit www.caesars.com/corporate. If you think you or someone you care about may have a gambling problem, call 1-877-770-STOP (1-877-770-7867).
About Awager
Awager is a pioneering iGaming technology company dedicated to redefining the online casino experience by bridging the gap between land-based casinos and virtual play. Through its proprietary and patented technology, Awager enables players to remotely access and interact with real, physical slot machines and electronic table games located on casino floors, delivering an authentic and immersive live gaming experience directly to their mobile devices and desktops. Awager's innovative solutions create dedicated broadcast studios for partners, complete with real-time camera views, sound captures, and cutting-edge interfaces, ensuring a trusted and familiar environment for players worldwide. Committed to revolutionizing the industry, Awager provides a unique and engaging omni-channel solution that brings the excitement of traditional casino play to the digital realm.
Online Casino apps & websites available in MI, NJ, PA, WV and ON only.
Must be 21+. See Caesars.com/sportsbook-and-casino, CaesarsPalaceOnline.com, or HorseshoeOnlineCasino.com for full terms. Void where prohibited.
Know When To Stop Before You Start®. Gambling Problem? MI, NJ, WV, PA (Affiliated with Harrah's Philadelphia): If you or someone you know has a gambling problem, crisis counseling and referral services can be accessed by calling 1-800-GAMBLER (1-800-426-2537) or WV: Visit 1800gambler.net; ON: Visit connexontario.ca or call 1-866-531-2600 or text CONNEX to 247247. Accruing Caesars Rewards credits is currently not available in Ontario when using Caesars Sportsbook & Casino, Caesars Palace Online Casino, and Horseshoe Online Casino. ©2025, Caesars Entertainment
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
Scotch-Brite Teams Up With Ally Love To Announce 'National Shine Brite Day'
Originally published on 3M News Center ST. PAUL, Minn., June 27, 2025 /3BL/ -- Scotch-Brite™, America's #1-selling scrub sponge brand, introduces National Shine Brite Day, a yearly celebration that invites people everywhere to see cleaning in a new light – shifting the mindset from a task on a to-do list into a way to express yourself, refresh your space and feel good doing it. National Shine Brite Day is part of the brand's " Brite Side of Clean " campaign, which launched earlier this spring to usher in a fresh era of cleaning, one that centers on joy, self-expression and the satisfaction of a job well done. Featuring an energetic 30-second spot set to Outkast's iconic early-2000s anthem 'So Fresh, So Clean,' the campaign invites everyone to dance through their chores and transform cleaning from a task into a powerful act of self-expression and positivity. To help kick off the celebration, Scotch-Brite has teamed up with Ally Love, Peloton Instructor, VP of instructor strategy and development, and on-air Today show contributor, as a Clean Partner. Known for her energy, motivation and love of movement, Ally is inspiring people to reframe their routines by pairing cleaning with music, dance and the kind of positive vibes that turn even the smallest tasks into mini celebrations. 'Cleaning is part of my daily routine – not just to reset my space; it's an act of mindfulness, movement and joy,' said Love. 'My process starts with my favorite playlist - it keeps the energy up and makes the experience more enjoyable and fun. I love seeing the physical transformation from messy to clean – it's a visual affirmation that my actions matter, that small acts have big impact. National Shine Brite Day is a reminder that cleaning is more than a task, it's an opportunity to celebrate the creativity and pride that comes with a clean and refreshed space.' June 26 holds a special significance for the brand as it marks the anniversary of Scotch-Brite's first appearance on shelves in 1958. Nearly seven decades later, the brand continues to be a pioneer in the cleaning category with innovative solutions that brighten homes and lives. 'National Shine Brite Day is about more than creating a clean space – it's about choosing to find joy in the process,' says Joe Paul, chief marketing officer, 3M Consumer Business Group. 'Scotch-Brite is committed to providing consumers with creative, sensorial solutions to cleaning – for every day and every mess.' Whether it's the satisfaction of a dramatic before-and-after, the thrill of discovering a clever cleaning hack, or the joy of dancing your way through chores - Scotch-Brite believes cleaning should feel good. The brand encourages everyone to find the sparkle, share the fun and help others see the 'brite side' too! For more information on 'The Brite Side of Clean' campaign, National Shine Brite Day and Scotch-Brite products, visit About 3M 3M (NYSE: MMM ) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at About Scotch-Brite™ For 65 plus years, the Scotch-Brite™ Brand has been brightening homes and lives with cleaning expertise and innovative solutions that power through tough messes and let you enjoy the feeling of clean. With our ever-expanding line of products, we are a trusted leader in cleaning and a staple in households worldwide. Learn more at SOURCE 3M Company Visit 3BL Media to see more multimedia and stories from 3M
Miami Herald
3 hours ago
- Miami Herald
Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / June 27, 2025 / RedChip Companies will air an interview with Greenwich LifeSciences, Inc. (Nasdaq:GLSI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, June 28, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S. Access the interview in its entirety at: In an exclusive previously recorded interview, Snehal Patel, CEO of Greenwich LifeSciences, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the Company's mission to prevent breast cancer recurrences through GLSI-100, a novel breast cancer vaccine immunotherapy combining the HER2-derived GP2 peptide with GM-CSF. Patel highlights the promising results from a prior Phase II trial showing no metastatic recurrences in immunized patients and details the global expansion of the ongoing Phase III FLAMINGO-01 trial, now active at more than 120 sites across the U.S. and Europe. He also outlines the Company's strategy to accelerate commercialization through advanced manufacturing readiness and strong academic partnerships, positioning GLSI-100 as a potential game-changer in the HER2-positive breast cancer treatment landscape. GLSI is a client of RedChip Companies. Please read our full disclosure at About Greenwich LifeSciences, Inc. Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2 protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75% of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. Greenwich LifeSciences has commenced a Phase III clinical trial, FLAMINGO-01. For more information on Greenwich LifeSciences, please visit the Company's website at About RedChip Companies RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights. To learn more about RedChip's products and services, please visit: "Discovering Tomorrow's Blue Chips Today"™ Follow RedChip on LinkedIn: Follow RedChip on Facebook: Follow RedChip on Instagram: Follow RedChip on Twitter: Follow RedChip on YouTube: Follow RedChip on Rumble: Subscribe to our Mailing List: Contact: Dave GentryRedChip Companies Inc.1-407-644-4256info@ --END-- SOURCE: RedChip Companies, Inc.
Associated Press
3 hours ago
- Associated Press
Ainnocence Launches BioSynthAI Platform for AI-Driven Synthetic Biology Product Discovery
'We are committed to advancing synthetic biology through the power of AI... BioSynthAI™'s launch is a major milestone in our mission to drive innovation for a more sustainable and healthier world.'— Dr. Lurong Pan MOUNTAIN VIEW, CA, UNITED STATES, June 27, 2025 / / -- Ainnocence, a next-generation biotech company specializing in AI-driven design, today announced the launch of its BioSynthAI™ platform, an advanced artificial intelligence solution for product discovery in the synthetic biology field. BioSynthAI™ leverages cutting-edge AI algorithms to optimize protein and enzyme activity through in-silico design, aiming to dramatically accelerate innovation across biopharmaceuticals and sustainable biotechnology. The launch comes at a time of rapid growth in synthetic biology – the global market was valued at $16.9 billion in 2024 and is projected to reach nearly $168 billion by 2035 ( ) – underscoring the strong demand for AI-driven solutions like BioSynthAI™. BioSynthAI™ is designed to streamline each stage of the synthetic biology development cycle. By integrating multi-omics data (genomic, proteomic, metabolomic, etc.) with expert biological models, the platform can design, simulate, and optimize biological systems significantly faster than traditional methods. Industry experts have suggested that intensive application of AI and automation could accelerate synthetic biology R&D timelines by as much as 20-fold, shrinking development cycles from a decade to mere months ( ). BioSynthAI™ realizes this potential by delivering optimized genetic designs and strain improvements in as little as a few hours, with end-to-end project turnarounds ranging from hours to two weeks. This represents a drastic reduction in time compared to conventional wet-lab experimentation, enabling researchers and companies to go from concept to prototype with unprecedented speed. Key Application Areas BioSynthAI™ is poised to drive breakthroughs across multiple sectors of synthetic biology. Key application areas include: • Green Biopharmaceuticals: Designing and optimizing therapeutic proteins and vaccines with environmentally sustainable processes. • Industrial Enzyme Development: Engineering high-efficiency enzymes for manufacturing, food processing, and other industrial applications. • Biofuel Production: Enhancing metabolic pathways in microbes to produce renewable biofuels (such as ethanol, biodiesel, or jet fuel) with higher yields and lower costs. • Biomaterial Synthesis: Creating novel biomaterials and bio-based chemicals (e.g. bioplastics, biofibers) as sustainable alternatives to petrochemical products. Core BioSynthAI™ Modules The BioSynthAI™ platform comprises four core modules, each addressing a critical step in the synthetic biology pipeline: • Gene Design Optimization: Uses AI-driven generative design to create and refine gene sequences or metabolic pathways for target molecules. This module explores billions of DNA or protein sequence variants to maximize performance traits such as enzyme activity, stability, and yield. • Strain Screening & Evolution: Leverages machine learning to predict the best-performing microbial strains and simulate directed evolution. It rapidly screens virtual strain variations and identifies optimal candidates for producing the desired product, significantly reducing the need for exhaustive lab trials. • Bioprocess Control: Employs artificial intelligence and automation to monitor and optimize bioprocess conditions in real time. From fermentation parameters to nutrient feed rates, this module adjusts process variables to ensure maximal efficiency and consistency in production. • Intelligent Production Integration: Connects the R&D pipeline with manufacturing, using AI to translate lab-scale successes into industrial-scale production. This module integrates data from pilot runs and manufacturing systems, enabling seamless scale-up and tech transfer for commercial bioproduction. Platform Strengths and Innovations BioSynthAI™'s strength lies in its comprehensive, end-to-end approach to synthetic biology innovation. Notable features and innovations of the platform include: • Multi-Omics Data Integration: The platform combines insights from genomics, transcriptomics, proteomics, metabolomics, and other omics data. This holistic view allows the AI to consider complex biological interactions and regulatory networks, leading to more accurate predictions and robust designs. • Synthetic Biology Expert Models: BioSynthAIT™ is built upon models trained on vast datasets and expert knowledge in synthetic biology and bioengineering. These domain-specific AI models incorporate known biochemical pathways, enzyme structures, and genetic design principles, giving the system a 'knowledge base' of what typically works in biological systems. • Experimental Data Validation Loop: Ainnocence has embedded a continuous validation mechanism in BioSynthAI™. Predicted designs (genes, enzymes, or strains) are experimentally synthesized and tested in Ainnocence's labs or partner facilities. The results are fed back into the AI models, allowing the platform to learn from real-world data and improving its predictive accuracy over time. • Rapid Project Turnaround: The platform is optimized for speed. Thanks to cloud computing and algorithmic efficiency, BioSynthAI™ can analyze and evaluate billions of possibilities within hours. In practice, Ainnocence offers deliverables from initial design to validated prototype in as fast as a few hours up to about two weeks, depending on project complexity. This rapid turnaround empowers companies to seize market opportunities and iterate quickly on ideas that would otherwise take months or years. 'At Ainnocence, we are committed to advancing synthetic biology through the power of AI,' said Dr. Lurong Pan, Founder and CEO of Ainnocence. 'BioSynthAI™ embodies that commitment by dramatically accelerating the product discovery process for our partners. By harnessing multi-omics data and our expert AI models, we can optimize enzymes, pathways, and entire organisms with unprecedented speed and precision. Our goal is to enable researchers and companies to tackle complex biological challenges – from developing greener pharmaceuticals to creating sustainable biofuels – faster and more efficiently than ever before. BioSynthAI™'s launch is a major milestone in our mission to drive innovation for a more sustainable and healthier world.' About Ainnocence Ainnocence is a California-based biotechnology company at the forefront of AI-driven design for drug discovery and synthetic biology. Founded in 2021, Ainnocence's radical AI platform is designed to minimize R&D risks and costs by up to 80%, and it boasts a computational capacity to screen up to 10 billion protein sequences or chemical compounds within hours ( ). By dramatically reducing discovery times while maintaining high success rates, Ainnocence empowers pharmaceutical, biotech, and industrial partners to pursue ambitious 'moonshot' projects. The company's AI technology has been used to accelerate the discovery of life-saving therapies and sustainable biomolecules, exemplifying Ainnocence's vision of AI as a catalyst for innovation in healthcare and environmental sustainability. For more information about BioSynthAI™ and Ainnocence's services in synthetic biology, please visit or contact [email protected]. Lurong Pan, PhD Ainnocence Inc +1 205-249-7424 [email protected] Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
